津药药业：关于子公司注射用甲泼尼龙琥珀酸钠获得巴拿马共和国卫生部注册证书的公告

Core Viewpoint - Tianjin Pharmaceutical Industry announced that its subsidiary, Tianjin Yaohe Pharmaceutical Co., Ltd., has received registration certification from the Ministry of Health of the Republic of Panama for its injectable methylprednisolone sodium succinate, allowing the company to produce and sell the product in the Panamanian market [1] Group 1 - The product is an injectable form of methylprednisolone sodium succinate [1] - The registration certification signifies a key milestone for the company in expanding its market presence in Panama [1] - This development may enhance the company's revenue potential through new market opportunities [1]